Keywords: Multiple Sclerosis, Multiple Sclerosis
Motivation: CEST MRI is a molecular imaging technique that has potential to image the changes of lipids and proteins during demyelination in human brain with multiple sclerosis (MS).
Goal(s): We aimed to explored the sensitivity of different CEST contrasts in differentiating MS brain from healthy control (HC) brain at 3T.
Approach: CEST MRI based on a 3D CUBE acquisition module was applied to image the brain of MS patients and HC subjects at a clinical 3T scanner.
Results: CEST MRI could sensitively identify MS from HC. Amide CEST, rNOE and MT showed significantly lower signals in the MS brain compared to HC brain.
Impact: This study demonstrated the alterations in CEST contrasts in the human brain with multiple sclerosis using a clinical 3T MRI. It provides valuable insights for the clinical application of CEST MRI in diagnosing multiple sclerosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords